Epi Biologics is a startup based in the United States, 1 tracked investor.
Epi Biologics is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Epi Biologics is listed in the Novartis Venture Fund portfolio as a life‑science company, indicating it operates in the biotechnology/biopharma space and is likely focused on developing therapeutics or therapeutic platforms.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.